Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SAN Group is a global biotechnology company headquartered in Austria, specializing in animal health, plant health, and green energy. The company was established by Erich Erber following the divestment of the Erber Group to DSM in 2020. Through its core subsidiaries, SAN Phar and SAN Agrow, the group develops and markets science-based solutions including veterinary vaccines, diagnostics, and sustainable crop protection products. SAN Group operates on four continents and maintains a strong focus on research and development to address challenges in global food security and environmental sustainability. The company is also notable for its commitment to carbon-neutral operations, exemplified by its "SAN Hydrogen" project.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The SAN Group.